Walleye Capital’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.54M Sell
180,462
-184,810
-51% -$3.71M ﹤0.01% 2596
2026
Q2
$8.12M Buy
+365,272
New +$7.62M 0.03% 567
2024
Q2
– Sell
-1,558
Closed -$1.61M – 5574
2024
Q1
$1.61M Buy
+1,558
New +$1.19M ﹤0.01% 2155

Other funds holding JBIO

Walleye Capital's JBIO Position: Q3 2026 in Review

Walleye Capital reduced its Jade Biosciences (JBIO) stake by 51% in Q3 2026, selling an estimated $3.71M and leaving 180,462 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

Walleye Capital first reported a position in JBIO in Q1 2024 and has held it in 3 quarters since. The position peaked at $8.12M in Q2 2026. 160 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Walleye Capital held 180,462 shares of Jade Biosciences worth $2.54M as of Q3 2026.
  • Walleye Capital sold 184,810 Jade Biosciences shares in Q3 2026, an estimated $3.71M.
  • Jade Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2596 holding.
  • Walleye Capital first reported a position in Jade Biosciences in Q1 2024 and has held it in 3 quarters since.
  • Walleye Capital's Jade Biosciences position peaked at $8.12M in Q2 2026.
  • 160 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.